We unveiled groundbreaking research at the AACR Annual Meeting (April 25–30, Chicago), marking the launch of MERFISH 2.0 and ADC OmniVUE™ panels, showcasing how spatial biology is transforming our understanding of the tumor-immune microenvironment and the discovery of emerging ADC (Antibody-Drug Conjugate) targets.

Explore all four posters presented at AACR to access cutting-edge data from our experts, showcasing the latest in spatial transcriptomics and proteomics to accelerate cancer research.

ABSTRACT TITLE
Combining Vizgen’s MERSCOPE® spatial transcriptomics and InSituPlex® spatial proteomics profiling to unravel the complexities of the tumor-immune microenvironment
Alexander Veith, Senior Field Applications Scientist

ABSTRACT TITLE
Configurable multiplex immunofluorescence panels for emerging ADC targets
Kevin Hwang, Ph.D., Senior Scientist, Research

ABSTRACT TITLE
New developments in spatial transcriptomics unlock insights into the tumor microenvironment with MERFISH 2.0™ and MERSCOPE Ultra™
Manisha Ray, Ph.D., Director, Applications Development

ABSTRACT TITLE
Bridging spatial proteomics and classical histopathology: advanced spatial analysis through H&E-enhanced multiplexed immunoprofiling
Michael Downing, Principal Image Analysis Scientist